344 related articles for article (PubMed ID: 14530796)
1. Antinociception and the new COX inhibitors: research approaches and clinical perspectives.
Herrero JF; Romero-Sandoval EA; Gaitan G; Mazario J
CNS Drug Rev; 2003; 9(3):227-52. PubMed ID: 14530796
[TBL] [Abstract][Full Text] [Related]
2. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.
Grösch S; Niederberger E; Geisslinger G
Expert Opin Investig Drugs; 2017 Jan; 26(1):51-61. PubMed ID: 27841017
[TBL] [Abstract][Full Text] [Related]
3. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
Everts B; Währborg P; Hedner T
Clin Rheumatol; 2000; 19(5):331-43. PubMed ID: 11055820
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.
Mazario J; Gaitan G; Herrero JF
Neuropharmacology; 2001 Jun; 40(7):937-46. PubMed ID: 11378164
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
[TBL] [Abstract][Full Text] [Related]
8. Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
Biava M; Porretta GC; Poce G; Battilocchio C; Botta M; Manetti F; Rovini M; Cappelli A; Sautebin L; Rossi A; Pergola C; Ghelardini C; Galeotti N; Makovec F; Giordani A; Anzellotti P; Tacconelli S; Patrignani P; Anzini M
Curr Med Chem; 2011; 18(10):1540-54. PubMed ID: 21428878
[TBL] [Abstract][Full Text] [Related]
9. [Selective inhibitors of cyclooxygenase-2. New agents against pain and inflammation].
Oliw E
Lakartidningen; 1997 May; 94(19):1797-801. PubMed ID: 9190460
[TBL] [Abstract][Full Text] [Related]
10. [New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors].
Bannwarth B; Berenbaum F
Rev Med Interne; 1999 Aug; 20 Suppl 3():341s-345s. PubMed ID: 10480184
[TBL] [Abstract][Full Text] [Related]
11. Pain management today - what have we learned?
Langford RM
Clin Rheumatol; 2006; 25 Suppl 1():S2-8. PubMed ID: 16741780
[TBL] [Abstract][Full Text] [Related]
12. [Analgesic effects of cyclooxygenase 2 inhibitors].
Jayr C
Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
[TBL] [Abstract][Full Text] [Related]
13. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors.
Buttar NS; Wang KK
Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851
[TBL] [Abstract][Full Text] [Related]
14. The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief.
Lee Y; Rodriguez C; Dionne RA
Curr Pharm Des; 2005; 11(14):1737-55. PubMed ID: 15892672
[TBL] [Abstract][Full Text] [Related]
15. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
Cicconetti A; Bartoli A; Ripari F; Ripari A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):139-46. PubMed ID: 14970772
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase inhibitors--current status and future prospects.
Dannhardt G; Kiefer W
Eur J Med Chem; 2001 Feb; 36(2):109-26. PubMed ID: 11311743
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiinflammatory drugs: benefits, risks, and COX-2 selectivity.
Halverson PB
Orthop Nurs; 1999; 18(6):21-6; quiz 27-8. PubMed ID: 11062611
[TBL] [Abstract][Full Text] [Related]
18. [Analgesic effects of cyclooxygenase 2 inhibitors].
Jayr C
Bull Cancer; 2004 May; 91 Suppl 2():S125-31. PubMed ID: 15899637
[TBL] [Abstract][Full Text] [Related]
19. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
20. Update on guidelines for the treatment of chronic musculoskeletal pain.
Schnitzer TJ
Clin Rheumatol; 2006; 25 Suppl 1():S22-9. PubMed ID: 16741783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
